Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;43(3):139-45.
doi: 10.5653/cerm.2016.43.3.139. Epub 2016 Sep 22.

The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response

Hyun Jong Park  1 , Geun Ho Lee  1 , Du Sik Gong  1 , Tae Ki Yoon  2 , Woo Sik Lee  2
Affiliations
Review

The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response

Hyun Jong Park et al. Clin Exp Reprod Med. 2016 Sep.

Abstract

Measurements of ovarian reserve play an important role in predicting the clinical results of assisted reproductive technology (ART). The ideal markers of ovarian reserve for clinical applications should have high specificity in order to determine genuine poor responders. Basal follicle-stimulating hormone levels, antral follicle count, and serum anti-Müllerian hormone (AMH) levels have been suggested as ovarian reserve tests that may fulfill this requirement, with serum AMH levels being the most promising parameter. Serum AMH levels have been suggested to be a predictor of clinical pregnancy in ART for older women, who are at a high risk for decreased ovarian response. We reviewed the prognostic significance of ovarian reserve tests for patients undergoing ART treatment, with a particular focus on the significance of serum AMH levels in patients at a high risk of poor ovarian response.

Keywords: Anti-Müllerian hormone; Fertilization in vitro; Infertility; Pregnancy rate.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Similar articles

See all similar articles

Cited by

References

    1. Spira A. The decline of fecundity with age. Maturitas. 1988;(Suppl 1):15–22. - PubMed
    1. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–154. - PubMed
    1. Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril. 1996;66:969–973. - PubMed
    1. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103:e9–e17. - PubMed
    1. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328–336. - PubMed